Iterum Therapeutics plc (ITRM)

Iterum Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	7.42	6.11	21.13	27.51	14.57	4.83
Short-Term Investments	10.83	17.86	39.71	53.9	0	0
Cash & Cash Equivalents	18.25	23.96	60.84	81.41	14.57	4.83
Cash Growth	-64.81%	-60.61%	-25.27%	458.81%	201.55%	-94.29%
Other Current Assets	0.81	1.63	1.61	1.86	6.9	6.89
Total Current Assets	19.05	25.6	62.44	83.27	21.47	11.72
Property, Plant & Equipment	0.04	0.05	0.07	0.09	0.42	0.57
Long-Term Investments	0	0	0	0	0.25	0.06
Goodwill and Intangibles	0	0	1.72	3.44	0	0
Other Long-Term Assets	0.53	0.61	2.6	4.72	10.65	13.4
Total Long-Term Assets	0.57	0.66	4.39	8.24	11.32	14.03
Total Assets	19.63	26.26	66.83	91.51	32.79	25.75
Accounts Payable	2.97	5	2.77	0.88	0.82	15.49
Current Debt	12.2	0	0	1.63	6.49	5.8
Other Current Liabilities	2.63	8.52	6.29	10.44	34.39	15.7
Total Current Liabilities	17.79	13.52	9.06	12.94	41.7	36.99
Long-Term Debt	7.89	18.96	28.47	24.9	35.85	7.63
Other Long-Term Liabilities	0.09	0.19	1.3	3.44	5.8	7.38
Total Long-Term Liabilities	7.98	19.14	29.77	28.33	41.65	15
Total Liabilities	25.78	32.66	38.83	41.28	83.35	51.99
Total Debt	20.09	18.96	28.47	26.53	42.34	13.43
Debt Growth	-33.33%	-33.41%	7.32%	-37.35%	215.37%	-4.77%
Retained Earnings	-468.4	-461.3	-422.93	-378.49	-286.93	-234.92
Comprehensive Income	0	0	-0.35	0	0	0
Shareholders' Equity	-6.15	-6.4	28	50.23	-50.56	-26.24
Net Cash / Debt	-1.84	5.01	32.37	54.88	-27.77	-8.59
Net Cash / Debt Growth	-	-84.53%	-41.02%	-	-	-
Net Cash Per Share	-0.12	0.39	2.65	5.04	-17.35	-8.88
Working Capital	1.26	12.08	53.38	70.33	-20.23	-25.27
Book Value Per Share	-0.40	-0.49	2.29	4.61	-31.59	-27.11

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).